Dr. David Samadi- Wizard Of The Prostate

This article is meant to highlight the work of a famous and innovative surgeon named Dr. David Samadi, and specifically the new system he invented for prostate cancer surgeries, known as the Samadi Modified Advanced Robotic Treatment.

Many people may have heard of Dr. Samadi through his weekly internet show, entitled “Let’s Make America Healthy Again with Dr. Samadi”. He also works as a contributor for Fox News, so he is definitely someone you may have heard from in the past. At the same time, he is chairman of the Urology department at Lennox Hill hospital in New York City. Obviously, this is a very busy man.

As a doctor, Dr. Samadi specializes in prostate surgery, and that’s where his new system comes in. It is a minimally invasive surgery that utilizes robotics to do surgery on the prostate without actually opening it up. It makes a few small holes rather than several large incisions. As such, the risk of complications goes down considerably. But, more on that later.

Dr. David Samadi was born in Iran, among a small Persian Jewish community. After the Iranian revolution of 1979, which ended 2500 years of continuous Persian rule, the country was in the hands of radical Muslim fundamentalists. Dr. Samadi and his younger brother left Iran and continued their educations in Belgium, London, and eventually the United States.

After achieving a full scholarship to New York State University, he earned degrees in biochemistry and medicine. He has earned a whole slew of awards during his time as a doctor. These include New York magazine’s “Best Doctor” award for 2009, 2010, 2011, 2012, and 2015. He also won the Patients Choice award for 2008, 2009, 2010, 2011, and 2013. His list of awards is actually too long to reproduce here.

Many times, traditional prostate surgery can damage nerves as a side effect, which will affect sexual function and/or continence for perhaps the rest of the patients life. This is a major problem that Dr. Samadi has resolved. This new technique is so non-invasive, the patient is normally home within a single day. Using advanced miniature robotics, tiny instruments are inserted through several 10-20 millimeter holes, and guided by the surgeon using a unique interface. Dr. Samadi has performed over 3600 successful operations of this type over the last ten years, with no major complications.

A person could not ask for a better contribution to medical science than the contribution of a method that makes surgery much easier on the patient. That alone is worthy of praise.

Dr. David Samadi’s  Social Media: www.youtube.com/user/RoboticOncology

WebMD teams up with CTCA

The Cancer Treatment Centers use a two-step process for treating those inflicted with this disease. The first step involves treating the disease and the second step involves evidence-informed supportive therapies. When treating cancer the Cancer Treatment Centers of America locations will use state of the art technologies that include chemotherapy, immunotherapy, and surgery and radiation therapy.

These treatments can weaken the body and ultimately the spirit of the individual fighting this disease. The second step of treatment includes healing the individual with therapies that can help combat nausea exhaustion and pain. These treatments will give each person the strength they need to continue on with the more invasive treatments. Cancer treatment centers know that there are no two cancers that are alike and believe in treating the individual and their cancer rather than a blanket treatment that is generalized not specific. When individuals come under the care of physicians of CTCA they are introduced to a team of professionals who will help them through each step of the treatment process. Cancer Treatment Centers of America have locations in Atlanta, Chicago, Philadelphia, Tulsa and Phoenix. CTCA is headquartered in Boca Raton Florida and was founded in 1988. This 5 hospital private care network was founded by Richard Stephenson and is a national for-profit network. Those seeking alternative and comprehensive cancer treatments will find a large network of doctors participating in cutting edge treatment options for all types of cancers. CTCA treats all stages of cancer. Customer care for patients is available twenty four hours a day and seven days a week. Click here

Working with Robotics: Dr. David Samadi

Early in 2017, Senator and Presidential nominee Mitt Romney was diagnosed with prostate cancer as he was nearing 70 years old. This affliction is nothing new. Many older men fear getting this cancer, and rightly so. Over 160,000 American men are going to be diagnosed with prostate cancer in the coming year, according to the American Cancer Society. Luckily, there is a new way to fight this cancer that will keep doctors from having to make tedious manual surgeries or subjecting the victim to harsh radiation therapies. Mitt Romney was one of the individuals who has been fortunate to receive a new and improved robotic surgery to remove the tumor before it spreads. According to Dr. David Samadi, Romney is now free and clear, and his treatment is being hailed as a less invasive way to fight cancer.

This new robotic surgery has been in the works for several years, and many doctors, Samadi included, have been working to bring it to market as soon as possible. While conventional surgeries are much more prone to human error and require a much larger incision, robotic surgeries do not. This means that no transfusion is needed for the surgery and most of the sexual and bladder functions that are so often lost during normal procedures remain intact.

Dr. David Samadi has been working on robotic surgery and urology his whole professional life. Born in Iran, he and his brother were forced to flee the country during the Iranian Revolution in 1979. Focusing on his medical career, Samadi graduated from S.U.N.Y. with his Master’s degree in 1994 and from Montefiore Medical Center with his M.D. He attended trainings at Albert Einstein College, and fellowships at Memorial Sloan-Kettering Cancer Center and Henri Mondor Hospital.

Samadi has been a prominent figure in the field ever since he first did his own robotic surgery and started to improve the process. He has now done over 7,000 such surgeries and is hailed as one of the premier surgeons for prostate cancer in the world. He has appeared on several talk television shows, and he has been published in several journals, including the Journal of Robotic Surgery, Journal of the Society of Laparoscopic Surgeons, and the World Journal of Urology. He has used his knowledge to also create an international lecture circuit. Dr. David Samadi has used his education and his profession to bring awareness and treatment to thousands of men around the world.

Dr. David Samadi’s career in prostate surgery

Fox News Channel contributor Dr. David Samadi is changing the face of healthcare, especially when it comes to men’s health. He was born in Iran in 1964. He moved to the United States when he was still a teenager where he completed high school. Soon after he attended Stony Brook University in the state of New York. He received a Bachelor of Science in Biochemistry and then continued at the Stony Brook University School of Medicine to receive his MD in 1994.

At Lenox Hill Hospital, Dr. David Samadi is the Chief of Robotic Surgery. He specializes in treating and diagnosing prostate, bladder, and kidney cancer, and also urologic diseases. He has performed thousands of operations, some of them in different countries. He has operated in 45 countries in his entire career. Dr. David Samadi is currently developing his own new prostate removal technique called SMART, or Samadi Modified Advanced Robotic Technique. It will bypass harmful side effects that traditional prostate surgery does such as impotence and incontinence. With this very advanced technology Dr. Samadi can achieve this goal.

How does this successful doctor achieve so much without getting burnt out? He focuses on positive energy, exercises, deep breathing, and avoids negative energy. He starts his day bright and early at 4:30 in the morning, before everyone wakes up. Work starts at 6am and he is on his feet all day. Before going home Dr. David Samadi checks on all his patients to see how they are doing. This creates trust and they know that they are taken care of. Because of this, word of mouth has been a factor in the doctor’s success. He is driven by results, so sitting in long board meetings does not work for him.

Another factor that he swears by is having a strict schedule. It may not work for everyone, but it does for him. Doing the same routine everyday yields better results he finds, so he does what works for him. Since Dr. David Samadi uses robotics when it comes to prostate surgery, he knows that this kind of technology will just grow over time. The celebrity doctor suggests investing in it will reap huge returns in the future. One of the best $100 he spent was on a nurse who retired recently. He says they are the foundation of healthcare in America and doctors could not do their job properly without them.

Read More: twitter.com/drdavidsamadi

Eric Lefkofsky and Tempus Address Medical Research

There are few people as influential in the world of technology and data as Eric Lefkofsky. Eric Lefkofsky has largely worked out of Chicago with a special focus on data aggregation. Right now Eric Lefkofsky is focused on his newest project, Tempus. Tempus is a company that is looking to fundamentally change the way that cancer care facilities operate by focusing on data aggregation for both patients and genomicdata. Tempus is a unique idea that is also a natural progression from what the healthcare field has been doing for the past few years with EHRs. Let’s take a closer look at Lefkofsky’s work and goals with the company.

Eric Lefkofsky saw firsthand how cancer care facilities around the country can struggle to get data from one place to another. One of the large problems is that notes and details are notoriously hard to keep track of. From handwritten doctor’s notes to poorly organized EHRs, life saving information can have a hard time getting to where it needs to go. Lefkofsky uses this broad problem to point out how it can make specific, focused issues for cancer care patients: if one medication works for one patient, why won’t it work for another patient across the country?

In order to answer the question we highlighted above Eric Lefkofsky decided to focus his work on Tempus. Tempus was established in 2015 and since then it has reached a valuation of over $700 million in total. Tempus operates like a digital overlay that seeks to bring together patient and genomic data into one convenient location that can be accessed by patients and medical professionals. Tempus is an operating system that pools and aggregates data in a variety of different ways. Over the years costs of genome sequencing have come down and now Tempus is going to push the envelope even further in a life saving effort.

Tempus is attempting to make a broad and sweeping change to the cancer care world. So far Tempus has been partnered up with several professional facilities including Duke University School of Medicine, Mayo Clinic and the Cleveland Clinic as well.

Eric Lefkofsky, an American Entrepreneur

Eric Lefkofsky is considered to be one of America’s greatest entrepreneurs. The teacher, writer, philanthropist and business man created a variety of successful companies which we all know and love. Dedicated to giving, Eric leads many successful charities and organizations as well.

Eric grew up in a suburban community located in northern Michigan. Son of a school teacher and engineer, Eric Lefkofsky pursued law as an education. He graduated with honors from the well respected University of Michigan. After graduating, Lefkofsky then pursued a higher education in the same state. He completed his studies at The University of Michigan Law School. It was here he managed to secure his Juris Doctor.

The cofounder and CEO of Tempus, Eric and his company are working tirelessly to bettering lives of cancer patients. Tempus is commonly known for their cancer battling technologies. This innovative company allows doctors the opportunity most are denied. Physicians are given personalized cancer care treatment opportunity through analytical and machine learning platforms.

Tempus provides genomic sequencing service. They also provide molecular analyzing and therapeutic data allowing doctors to make the most accurate decisions. These decisions are based on real time data.
Eric Lefkofsky is also the cofounder of Lightbank. This financial organization specializes in investments. Lightbank offers various venture capitalist investment opportunities. The most known companies Lightbank invest in are Groupon, Mediaocean and InnerWorkings. Although the headquarters is located in Chicago, Loghtbank has made investments with companies across the nation.

Eric is also known for his professional teaching career. He has worked alongside many prestigious schools in the Midwest region. Eric teaches a wide range of courses providing insight on his professional and educational background.

Eric has taught Applied Technology at Kellstadt Graduate School of Business. He has also taught a course on Disruptive Business Models at Northwestern University. At Chicago Booth School of Business, Eric teaches a course on entrepreneurship and web based businesses. For more info about us: http://www.bizjournals.com/chicago/news/2016/10/20/groupon-founder-eric-lefkofsky-joins-steppenwolf.html click here.

The cofounder of Groupon is much more than a business man. With a passion for helping the community, Eric has since joined the Giving Pledge. The Giving Pledge is a campaign created by Bill Gates and Warren Buffett to encourage wealthy people to contribute their wealth to philanthropic causes.

Eric Lefkofsky also created a charitable trust. Content on helping others, Eric started the Lefkofsky foundation in 2006. The foundation supports science and children foundations. The Lefkofsky Foundation has collectively help fund over fifty total organizations.

Eric Lefkofsky is One of the Leaders in the Field

Eric Lefkofsky Business

Many people today want to learn how to take their health to a new level. Millions of people every year struggle with diabetes and high blood pressure. For the vast majority of these people, a few lifestyle changes completely transform their health in less than a year. Now is a great time to learn about your health because there is so much information available.

There are a lot of companies that are taking healthcare industry by storm. These companies are transforming the way that people conduct their health, and they are ready for any challenge that comes their way. Eric Lefkofsky is one of the leaders in the business world who is tired of the typical healthcare system. He is working on a lot of projects in his business that will help other people throughout the world.


Many people like Eric Lefkofsky are frustrated with the healthcare system today. There is more technology than ever before, but the cost of health care continues to increase every year. Not only that, but he is tired of seeing people struggle with their health and wellness because they lack basic information.

Everyone knows that they should eat healthy and exercise. However, few people today are actually doing this. It is vital for people to start taking their heathy seriously. Eric Lefkofsky employees in his business are working on ways that they can teach people basic steps to get out of bad health. The company has already had success with many people who wanted transform their health.

Eric Lefkofsky

When it comes to new technology in the world of healthcare, Eric Lefkofsky is one of the leaders in the field. However, it is also important to know that he truly cares about helping people. Although he runs a successful company, he is not just doing it for the money. He has a track record of success in helping his customers feel better and more energetic. In the world we live in today, the cost of healthcare continues to increase every year. Eric Lefkofsky is fighting to change that.

About Eric Lefkofsky: www.bizjournals.com/chicago/news/2017/04/12/groupon-co-founder-moves-to-help-youth-access-art.html

The Business Strategy behind Clay B. Siegall Laudable Achievements

People excel by having access to secrets. These so-called secrets are not actually what they are called. It is the unrelenting adherence of individuals to them that make them one. Everybody may have access to them, but not everybody can hold-on to them in trying situations. Call them strategies, you will not be wrong. Clay B. Siegall has one strategy that has kept him going all these years. I got to know it when he was responding to questions in a recent interview. In his words, “Learn as much as you can; interact with very smart people who have expertise in many areas.” Narrowing this strategy to his profession, he put it this way: “An important component of our business strategy is collaborating with other industry leaders and innovators in oncology drug development.” He never sees himself or the company he runs as a island of knowledge, but can we find instances where he put this strategy into practice?


Clay B. Siegall holds a doctorate degree in Genetics from George Washington University. He is a Co-founder as well as the President, Chief Executive Officer and Board Chairman of Seattle Genetics since the inception of company in 1998. Being a specialist on targeted cancer therapies, Dr. Siegall entrenched into the fibers of the company a tradition of rigorous research, scientific innovation, drug development practices and unrelenting passion for assisting patients. Under his watch, the company has developed a number of effective antibody-drug conjugates (ADCs) with the FDA in 2011 approving the company’s first ADC product by the name ADCETRIS® (brentuximab vedotin). Thereafter, the company went into collaboration with Takeda Pharmaceutical Company making the drug a global brand available in over 65 countries.


Seattle Genetics has been involved in multiple strategic licenses for the purpose of financing its ADC technology. The company has had corporate agreements with companies such as Pfizer, GlaxoSmithKline, AbbVie and Genetics (Roche) generating well beyond $350 million. With the help of its numerous internal and collaborator programs, over 20 ADCs are in clinical development stages using Seattle Genetics’ technology.


Clay B. Siegall is one of the few indispensable hands combating the monster called cancer and providing hope of the eventual obliteration of the disease from planet earth.